Physician

William B Wolf, M.D.

According to 2025 Medicare claims, William Wolf, M.D. (NPI: 1316262124) practices addiction medicine, with the plurality of this provider's patient population coming from Caswell, NC. This provider's primary affiliated billing organization is STARTING POINT OF VIRGINIA, P.C. (NPI: 1760949127; TIN: 833261750) and primary practice location at 24210-8093.

Wolf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 29 traditional Medicare patients, billed 193 HCPCS/CPT codes, and received $25,558 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 279 prescription claims across 35 beneficiaries totaling $21,812 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 3 records totaling $58. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $302,501 to $25,558. Similarly, Part D prescription costs have fallen sharply in recent years, from $27,477 to $21,812. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$323K$646K2019 Medicare payment: $302,501 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $549,189 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $645,899 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $9,594 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $27,554 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $25,558 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20198728,444$302,501
202019552,663$549,189
202125455,054$645,899
202229153$9,594
202326245$27,554
202429193$25,558

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$52K2020 Drug cost: $27,477 (USD; Tot_Drug_Cst)2021 Drug cost: $51,585 (USD; Tot_Drug_Cst)2022 Drug cost: $52,138 (USD; Tot_Drug_Cst)2023 Drug cost: $23,924 (USD; Tot_Drug_Cst)2024 Drug cost: $21,812 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202020104$27,477
202135248$51,585
202255317$52,138
202324243$23,924
202435279$21,812

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0481Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms23121$140
G0480Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms1138$99

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl2214,121$14,068
SuboxoneBuprenorphine Hcl/Naloxone Hcl18427$7,359
Buprenorphine HclBuprenorphine Hcl20280$72

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$58Braeburn Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for William B. Wolf, M.D.?

Tedicare shows public-source Medicare data for William B. Wolf, M.D. (NPI 1316262124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William B. Wolf, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William B. Wolf, M.D.?

William B. Wolf, M.D. is linked to STARTING POINT OF VIRGINIA, P.C. (billing NPI 1760949127) in the available physician profile data.

Does William B. Wolf, M.D. have Open Payments data?

William B. Wolf, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.